Search

everythinglearnresearchcommunity

for

Search:↓

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp itching is common and hard to diagnose due to the complex nerve structure of the scalp.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

Different methods of preparing Platelet-Rich Plasma (PRP) can affect wound healing and hair regrowth in plastic surgery. Using a kit with specific standards helps isolate PRP that meets quality criteria. Non-Activated PRP and Activated PRP have varying effects depending on the tissue and condition treated. For hair regrowth, Non-Activated PRP increased hair density more than Activated PRP. Both treatments improved various aspects of scalp health.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Minoxidil absorbs poorly through skin, with low risk of side effects at 1-2% concentration.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Beard cells, unlike scalp cells, produce growth factors in response to testosterone, which may explain differences in hair growth.

Alopecia patients had similar element levels to normal people, except for differences in copper and low selenium.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Healthy scalp reduces hair loss by managing oxidative stress.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Scalp seborrheic dermatitis is a common skin condition linked to oil production and bacteria, with specific diagnostic features and treatments like antifungals and corticosteroids.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.